Document Preview Unavailable

Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer.

Hendricksen, K; Cornel, E B; de Reijke, T M; Arentsen, H C; Chawla, S; et al.  The Journal of urology Vol. 187, Iss. 4,  (April 2012): 1195-1199.

You might have access to this document